With a strong background in specialty glass and coatings Trajan Scientific and Medical (Trajan) has introduced a new range of microscopy products.
Trajan's General Manager, Microscopy Products, Ms Angela Tomisich says that microscopy is a key technique where premium products can be brought to market to have a positive impact on patient outcomes, in line with the Trajan vision.
“By working closely with partners in pathology and healthcare, we want to continue to develop our range of products in ways that have a positive impact on the diagnostic process. In a world that is increasingly driven to drive down healthcare costs, we want to play a strong role in ensuring that patient outcomes are not compromised.” said Ms Tomisich.
Ms Tomisich is a Director on the Board of Trajan and brings a breadth of management and clinical research experience. She attained a Bachelor of Applied Science (Applied Chemistry) from RMIT, Melbourne, Australia, and Bachelor of Science (Biomedical Science) from Deakin University, Melbourne, Australia. In 2006, she was also placed on the Cornell University Dean’s List following a cell physiology and genomics program in Ithaca, USA.
Prior to Trajan, Ms Tomisich was involved the monitoring of clinical trials in Australia and New Zealand for protocols that were complex and required knowledge in advanced therapeutic areas, including oncology, cardiology, and neurology.
Ms Tomisich is also a member of the Digital Pathology Association, and has a keen interest in emerging methods and technologies to improve diagnostic practices.
For a preview of Trajan’s capabilities in microscopy products, please view the page below or contact the Trajan team directly to discuss your microscopy requirements.
Angela Tomisich, General Manager, Microscopy Products
Pathology in Practice looks into a simple but effective solution to stop tissue sections becoming detached and floating away when faced with harsh processing conditions typical of methods such as immunohistochemistry and in situ hybridization.